Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Reduces Infarct Size Independently of Sodium Glucose Cotransporter-2

Original language	English
Pages (from-to)	276-279
Number of pages	4
Journal	Circulation
Volume	147
Issue number	3
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.122.061688
Publication status	Published - 17 Jan 2023

body weight, empagliflozin, glucose, infarct size, ischemia/reperfusion, ketones, sodium-glucose cotransporter 2 inhibitor

ID: 31315344

Generic Portal